Pharmaceutical Analysis & Statistics, November 2014 (p100)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Therapeutics, Drug, Cancer, more »

2971-3010 of about 20 000 reports

Purchase Reports From Reputable Market Research Publishers

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary IPCA Laboratories Limited (IPCA) is a generic pharmaceutical company. It undertakes the manufacturing and distribution of active pharmaceutical ingredients and formulations. The company's APIs ...

  • Industries : Drug and Medication
  • Countries : Canada, India, Australia
Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include ...

  • Industries : Therapy
  • Countries : United States
Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis Review

Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Indoco Remedies Limited (Indoco Remedies) is a pharmaceutical company. The company manufactures and markets formulations and active pharmaceutical ingredients. It offers products in the fields ...

  • Industries : Drug and Medication
Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company ...

  • Industries : Drug and Medication
  • Countries : India, United States, World, Australia, South Africa, China
Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis Review

Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Nectar Lifesciences Ltd (NecLife) is an integrated niche pharmaceutical player developing specialized pharmaceutical intermediates, finished dosage formulations and active pharmaceutical ingredients. ...

  • Industries : Drug and Medication
Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Parabolic Drugs Limited (PDL) is a pharmaceutical intermediate company. The company focuses on development and manufacturing of APIs (Active Pharmaceutical Ingredients) and API intermediates. It ...

  • Industries : Drug and Medication
  • Countries : World
Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic SWOT Analysis Review

Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Polydex Pharmaceuticals Limited (PPL) is a pharmaceutical company. The company manufactures and sells bulk quantities of dextran and derivative products to large pharmaceutical companies throughout ...

  • Industries : Pharmaceutical
  • Countries : Canada
Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Surya Pharmaceutical Limited (Surya Pharmaceutical) is a pharmaceutical company. The company discovers, produces and markets active pharmaceutical ingredients (APIs), finished drug formulations ...

  • Industries : Drug and Medication
  • Countries : Singapore, United States
The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, ...

  • Industries : Pathology
  • Countries : United States
Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Financial and Strategic SWOT Analysis Review

Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is a pharmaceutical company. The company manufactures and sells pharmaceutical drugs to healthcare industries. It operates through its products segments, ...

  • Industries : Pharmaceutical
Weinmann Gerate fur Medizin GmbH + Co. KG - Strategic SWOT Analysis Review

Weinmann Gerate fur Medizin GmbH + Co. KG - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Weinmann Gerate fur Medizin GmbH + Co. KG (Weinmann) is a medical devices manufacturing company. The company develops, produces and distributes diagnostic, therapeutic and life-saving system solutions. ...

  • Industries : Pathology
Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Xenetic Biosciences plc (Xenetic) is a bio-pharmaceutical company. It carries out the development of drugs for cancer therapies and vaccines. The company has developed proprietary patented technologies ...

  • Industries : Drug and Medication
  • Countries : United States
Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis Review

Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Twilight Litaka Pharma Ltd. (TL Pharma) is a pharmaceutical company. The company manufactures drugs and formulations in the form of tablets, capsules, ointment, and liquids. Its products include ...

  • Industries : Drug and Medication
Wintac Limited (524758) - Financial and Strategic SWOT Analysis Review

Wintac Limited (524758) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Wintac Limited (Wintac) is a pharmaceutical and healthcare company. The company develops, manufactures and markets pharmaceutical formulations for healthcare markets. It offers products through ...

  • Industries : Drug and Medication
  • Countries : India
Enzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Review

Enzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Enzymatica AB (Enzymatica) is a biotechnology company. It carries out the research, development and registration of medical products, based on a patented enzyme technology. The company focuses ...

  • Industries : Pathology
  • Countries : Sweden, United States
Hanmi Pharmaceuticals, Co. Ltd. (128940) - Financial and Strategic SWOT Analysis Review

Hanmi Pharmaceuticals, Co. Ltd. (128940) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Hanmi Pharmaceuticals, Co. Ltd. (Hanmi Pharma) is a pharmaceutical products manufacturer. The company manufactures and supplies prescription drugs and over-the-counter (OTC) drugs. Its prescription ...

  • Industries : Pharmaceutical
  • Countries : South Korea
Mebiopharm Co., Ltd. (4580) - Financial and Strategic SWOT Analysis Review

Mebiopharm Co., Ltd. (4580) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mebiopharm Co., Ltd. (Mebiopharm) is a pharmaceutical company. The company develops various pharmaceutical products. Its product portfolio includes MBP- 426, MBP-Y003, MBP- Y003b, MBP- Y004, MBP- ...

  • Industries : Drug Delivery Technology
  • Countries : Netherlands, Japan
PD-Rx Pharmaceuticals, Inc - Strategic SWOT Analysis Review

PD-Rx Pharmaceuticals, Inc - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary PD-Rx Pharmaceuticals, Inc (PD-Rx) is a pharmaceutical company. The company distributes pharmaceutical products to healthcare industry. Its products include dispensing systems, forms, inventory ...

  • Industries : Pharmaceutical
  • Countries : United States
Chunghwa Chemical Synthesis & Biotech Co. Ltd. (1762) - Financial and Strategic SWOT Analysis Review

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (1762) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) is an active pharmaceutical ingredient (API) manufacturer. It undertakes development, manufacturing and commercialization of API's. The company ...

  • Industries : Drug and Medication
NeuroGenesis, Inc. - Strategic SWOT Analysis Review

NeuroGenesis, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary NeuroGenesis, Inc. (Neurogenesis) is a pharmaceutical company. The company develops and sells nutritional supplement products for the treatment of substance abuse in children and adults. Its products ...

  • Industries : Vitamin and Supplement
  • Countries : United States
Pharmaxis Limited (PXS) - Financial and Strategic SWOT Analysis Review

Pharmaxis Limited (PXS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pharmaxis Ltd. (Pharmaxis) is a pharmaceutical company. The company develops products for diagnosis and treatment of chronic respiratory and immune disorders. It offers products such as include ...

  • Industries : Pathology
  • Countries : Australia, South Korea
Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Acasti Pharma Inc. (Acasti) is a biopharmaceutical company. The company researches, develops and commercializes active pharmaceutical ingredients for the management of cardiometabolic disorders. ...

  • Industries : Pathology
  • Countries : Canada
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review

ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary ChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company. The company discovers, and develops orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ...

  • Industries : Pathology
  • Countries : United States
Entia Biosciences, Inc. (ERGO) - Financial and Strategic SWOT Analysis Review

Entia Biosciences, Inc. (ERGO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Entia Biosciences, Inc. (EBI) is a biotechnology company. The company offers nutrigenomics solutions for organic health, beauty and agriculture. Its solutions include ErgoD2, teloderm anti-aging ...

  • Industries : Pathology
  • Countries : United States
Intec Pharma ltd. (INTP) - Financial and Strategic SWOT Analysis Review

Intec Pharma ltd. (INTP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Intec Pharma ltd. (Intec Pharma) is a drug development company. The company develops and markets improved formulations of existing drugs. It offers products that include Carbidopa / Levodopa GR, ...

  • Industries : Pathology
Merrimack Pharmaceuticals, Inc. (MACK) - Financial and Strategic SWOT Analysis Review

Merrimack Pharmaceuticals, Inc. (MACK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Merrimack Pharmaceuticals, Inc. (Merrimack) is a biopharmaceutical company. The company discovers, develops and provides therapies for the treatment of autoimmune disease and cancer. Its drug products ...

  • Industries : Pharmaceutical
  • Countries : United States
Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pivotal Therapeutics Inc. (Pivotal Therapeutics) is a pharmaceutical company. The company produces and markets therapeutic products for cardiovascular disease and overall health. Its products include ...

  • Industries : Therapy
  • Countries : United States, Canada
Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Orpea SA (Orpea) is a healthcare service provider. The company offers clinical care, rehabilitation and psychiatric services. Its clinical care services include sub acute care and rehabilitation, ...

  • Industries : Therapy
  • Countries : Switzerland, Spain, Italy, France, Belgium
Mayne Pharma Group Limited (MYX) - Financial and Strategic SWOT Analysis Review

Mayne Pharma Group Limited (MYX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceutical company. The company develops, manufactures, and commercializes branded and generic pharmaceutical products. Its products include Aspirin ...

  • Industries : Pharmaceutical
  • Countries : Australia
Advanced Refractive Technologies, Inc. - Strategic SWOT Analysis Review

Advanced Refractive Technologies, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Advanced Refractive Technologies, Inc. (ART) is a medical device manufacturer. The company designs, develops, manufactures, and markets ophthalmic devices and pharmaceutical agents for the ophthalmology ...

  • Industries : Pathology
  • Countries : United States

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Bristol-Myers Squibb Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.